Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QBW251 in Subjects With Bronchiectasis
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
A Study to Assess the Safety and Efficacy of ECF843 vs Vehicle in Subjects With Dry Eye Disease
- Status
- COMPLETED
- Phase
- PHASE2
Study of Efficacy and Safety of NIS793 (With and Without Spartalizumab) in Combination With SOC Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
- Status
- TERMINATED
- Phase
- PHASE2
Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Efficacy and Safety of MAS825 in Patients With COVID-19
- Status
- COMPLETED
- Phase
- PHASE2
Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia
- Status
- COMPLETED
- Phase
- PHASE2
Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia
- Status
- COMPLETED
- Phase
- PHASE3
Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm
- Status
- COMPLETED
- Phase
- PHASE3
Managed Access Programs for ABL001, Asciminib
- Status
- AVAILABLE
- Phase
- N/A
Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease
- Status
- COMPLETED
- Phase
- PHASE3
An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Lamprene Multiple Patient Program
- Status
- AVAILABLE
- Phase
- N/A
Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia
- Status
- COMPLETED
- Phase
- PHASE2
Study of Capmatinib and Spartalizumab/Placebo in Advanced NSCLC Patients With MET Exon 14 Skipping Mutations
- Status
- TERMINATED
- Phase
- PHASE2
Study to Assess Safety, Tolerability and Phamacokinetics of KAE609 Administered Intravenously in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Pharmacokinetics, Safety, Tolerability and Efficacy of a New Artemether-lumefantrine Dispersible Tablet in Infants and Neonates <5 kg Body Weight With Acute Uncomplicated Plasmodium Falciparum Malaria
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
PoC Study to Evaluate the Efficacy and Safety of Secukinumab 300 mg in Patients With Lichen Planus
- Status
- COMPLETED
- Phase
- PHASE2